COMIRNATY (Tozinameran [mRNA]) COVID-19 VACCINE 10 micrograms/0.2 mL concentrated suspension for injection vial, Pfizer Australia Pty Ltd, CON-887

The products must be supplied with the labels that were considered and agreed to as part of the evaluation of the application dated 15 November 2021,  associated email correspondence, and mock-up labels  under section 25 of the Therapeutic Goods Act 1989, being       EU  Labels  -  batches  PAA173907,  PAA173908,  PAA181915,  PAA181046,  PAA180830,  PAA181041,  PAA181770,  PAA181911, PAA181047,  PAA181044,  PAA181045.US Emergency Use Labels - batches  PAA177913,  PAA178418,  PAA178420. NOTE US Emergency Use Labels do not have the tradename (COMIRNATY), generic name (tozinameran) or expiration date printed on the vial and/or carton labels. Determining the actual expiry date of any vaccine supplied with these labels will require the QR code on the carton to be scanned, followed by navigation to the page containing the expiry information.